TiO2 Nanoparticles in Cancer Therapy as Nanocarriers in Paclitaxel’s Delivery and Nanosensitizers in Phototherapies and/or Sonodynamic Therapy


Cite item

Full Text

Abstract

Nanomaterials have been offering improvements in different areas due to their unique characteristics, but cytotoxicity associated with their use is still a topic that concerns researchers. Causing cell death, at first glance, may seem to be a problem and the studies regarding signaling pathways involved in this toxicity are still in their infancy. However, there are scenarios in which this feature is desirable, such as in cancer treatment. Anti-cancer therapies aim to eliminate the cells of malignant tumors as selectively as possible. From this perspective, titanium dioxide (TiO2) nanoparticles (NPs) deserve to be highlighted as important and efficient tools. Besides being able to induce cell death, these NPs can also be used to deliver anti-cancer therapeutics. These drugs can be obtained from natural sources, such as paclitaxel (an antitumoral molecule derived from a vegetal source). The present review aims to explore the recent knowledge of TiO2 NPs as nanocarriers (promoting the nanodelivery of paclitaxel) and as nanosensitizers to be used in phototherapies and/or sonodynamic therapy aiming to treat cancer. Signaling pathways triggered by this nanomaterial inside cells leading to apoptosis (a desirable fate when targeting tumor cells) and challenges related to the clinical translation of these NPs will also receive attention.

About the authors

Fernanda Tonelli

Department of Biochemistry, Federal University of São João del Rei, UFSJ

Author for correspondence.
Email: info@benthamscience.net

Flávia Tonelli

Department of Biochemistry, Federal University of São João del Rei, UFSJ

Email: info@benthamscience.net

Helon Cordeiro

Department of Biochemistry and Tissue Biology, University of Campinas, UNICAMP

Email: info@benthamscience.net

References

  1. Siegel, R.L.; Miller, K.D.; Wagle, N.S.; Jemal, A.; Wagle, N.S.; Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin., 2023, 73(1), 17-48. doi: 10.3322/caac.21763 PMID: 36633525
  2. Vasan, N.; Baselga, J.; Hyman, D.M. A view on drug resistance in cancer. Nature, 2019, 575(7782), 299-309. doi: 10.1038/s41586-019-1730-1 PMID: 31723286
  3. Bukhari, S.N.A. Emerging nanotherapeutic approaches to overcome drug resistance in cancers with update on clinical trials. Pharmaceutics, 2022, 14(4), 866. doi: 10.3390/pharmaceutics14040866 PMID: 35456698
  4. Li, R.; Chen, Z.; Dai, Z.; Yu, Y. Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance. Cancer Biol. Med., 2021, 18(2), 388-400. doi: 10.20892/j.issn.2095-3941.2020.0328 PMID: 33755377
  5. Qu, Y.; Kang, M.; Cheng, X.; Zhao, J. Chitosan-coated titanium dioxide-embedded paclitaxel nanoparticles enhance anti-tumor efficacy against osteosarcoma. Front. Oncol., 2020, 10, 577280. doi: 10.3389/fonc.2020.577280 PMID: 33014883
  6. Zhu, L.; Chen, L. Progress in research on paclitaxel and tumor immunotherapy. Cell. Mol. Biol. Lett., 2019, 24(1), 40. doi: 10.1186/s11658-019-0164-y PMID: 31223315
  7. Hasanzadeh Kafshgari, M.; Kah, D.; Mazare, A.; Nguyen, N.T.; Distaso, M.; Peukert, W.; Goldmann, W.H.; Schmuki, P.; Fabry, B. Anodic titanium dioxide nanotubes for magnetically guided therapeutic delivery. Sci. Rep., 2019, 9(1), 13439. doi: 10.1038/s41598-019-49513-2 PMID: 31530838
  8. Çeşmeli, S.; Biray-Avci, C. Application of titanium dioxide (TiO2) nanoparticles in cancer therapies. J. Drug Target., 2018, 2018, 1-13. PMID: 30252540
  9. Li, C.; Wang, J.; Wang, Y.; Gao, H.; Wei, G.; Huang, Y.; Yu, H.; Gan, Y.; Wang, Y.; Mei, L.; Chen, H.; Hu, H.; Zhang, Z.; Jin, Y. Recent progress in drug delivery. Acta Pharm. Sin. B, 2019, 9(6), 1145-1162. doi: 10.1016/j.apsb.2019.08.003 PMID: 31867161
  10. Sungur, Ş. Titanium dioxide nanoparticles. In: Handbook of Nanomaterials and Nanocomposites for Energy and Environmental Applications; Kharissova, O.V.; Torres-Martínez, L.M.; Kharisov, B.I., Eds.; Springer: Amsterdam, 2020; pp. 1-18. doi: 10.1007/978-3-030-11155-7_9-1
  11. Verma, V.; Al-Dossari, M.; Singh, J.; Rawat, M.; Kordy, M.G.M.; Shaban, M. A review on green synthesis of TiO2 NPs: Photocatalysis and antimicrobial applications. Polymers, 2022, 14(7), 1444. doi: 10.3390/polym14071444 PMID: 35406317
  12. Mousavi, S.M.; Hashemi, S.A.; Ghasemi, Y.; Atapour, A.; Amani, A.M.; Savar, D.A.; Babapoor, A.; Arjmand, O. Green synthesis of silver nanoparticles toward bio and medical applications: Review study. Artif. Cells Nanomed. Biotechnol., 2018, 46(sup3), 855-872. doi: 10.1080/21691401.2018.1517769 PMID: 30328732
  13. Salama, B.; El-Sherbini, E.S.; El-Sayed, G.; El-Adl, M.; Kanehira, K.; Taniguchi, A. The effects of TiO2 nanoparticles on cisplatin cytotoxicity in cancer cell lines. Int. J. Mol. Sci., 2020, 21(2), 605. doi: 10.3390/ijms21020605 PMID: 31963452
  14. Gojznikar, J. Zdravković B.; Vidak, M.; Leskošek, B.; Ferk, P. TiO2 nanoparticles and their effects on eukaryotic cells: A double-edged sword. Int. J. Mol. Sci., 2022, 23(20), 12353. doi: 10.3390/ijms232012353 PMID: 36293217
  15. Shabbir, S.; Kulyar, M.F.A.; Bhutta, Z.A.; Boruah, P.; Asif, M. Toxicological consequences of titanium dioxide nanoparticles (TiO2NPs) and their jeopardy to human population. Bionanoscience, 2021, 11(2), 621-632. doi: 10.1007/s12668-021-00836-3 PMID: 33520589
  16. Brassolatti, P.; de Almeida, R.J.M. Franco de, G.K.; de Castro, C.A.; Flores, L.G.L.; Dias de, L.F.B.; Pedrino, M.; Assis, M.; Nani, L.M.; Cancino-Bernardi, J.; Speglich, C.; Frade, M.A.; de Freitas, A.F. Functionalized titanium nanoparticles induce oxidative stress and cell death in human skin cells. Int. J. Nanomedicine, 2022, 17, 1495-1509. doi: 10.2147/IJN.S325767 PMID: 35388270
  17. Jafari, S.; Mahyad, B.; Hashemzadeh, H.; Janfaza, S.; Gholikhani, T.; Tayebi, L. Biomedical applications of TiO2 nanostructures: Recent advances. Int. J. Nanomedicine, 2020, 15, 3447-3470. doi: 10.2147/IJN.S249441 PMID: 32523343
  18. Sun, Q.; Ishii, T.; Kanehira, K.; Sato, T.; Taniguchi, A. Uniform TiO 2 nanoparticles induce apoptosis in epithelial cell lines in a size-dependent manner. Biomater. Sci., 2017, 5(5), 1014-1021. doi: 10.1039/C6BM00946H PMID: 28338134
  19. Rahmani Kukia, N.; Rasmi, Y.; Abbasi, A.; Koshoridze, N.; Shirpoor, A.; Burjanadze, G.; Saboory, E. Bio-Effects of TiO2 Nanoparticles on Human Colorectal Cancer and Umbilical Vein Endothelial Cell Lines. Asian Pac. J. Cancer Prev., 2018, 19(10), 2821-2829. PMID: 30361551
  20. Zhang, L.; Xie, X.; Zhou, Y.; Yu, D.; Deng, Y.; Ouyang, J.; Yang, B.; Luo, D.; Zhang, D.; Kuang, H. Gestational exposure to titanium dioxide nanoparticles impairs the placentation through dysregulation of vascularization, proliferation and apoptosis in mice. Int. J. Nanomedicine, 2018, 13, 777-789. doi: 10.2147/IJN.S152400 PMID: 29440900
  21. Waseem, M.; Kaushik, P.; Dutta, S.; Chakraborty, R.; Hassan, M.I.; Parvez, S. Modulatory role of quercetin in mitochondrial dysfunction in titanium dioxide nanoparticle-induced hepatotoxicity. ACS Omega, 2022, 7(4), 3192-3202. doi: 10.1021/acsomega.1c04740 PMID: 35128232
  22. He, Q.; Zhou, X.; Liu, Y.; Gou, W.; Cui, J.; Li, Z.; Wu, Y.; Zuo, D. Titanium dioxide nanoparticles induce mouse hippocampal neuron apoptosis via oxidative stress- and calcium imbalance-mediated endoplasmic reticulum stress. Environ. Toxicol. Pharmacol., 2018, 63, 6-15. doi: 10.1016/j.etap.2018.08.003 PMID: 30114659
  23. Fattori, A.C.M.; Brassolatti, P.; Feitosa, K.A.; Matheus, P.; Correia, R.O.; Albuquerque, Y.R.; Rodolpho, J.M.A.; Luna, G.L.F.; Cancino-Bernardi, J.; Zucolotto, V.; Speglich, C.; Rossi, K.N.Z.P.; Freitas Anibal, F. Titanium dioxide nanoparticle (TiO2 NP) induces toxic effects on la-9 mouse fibroblast cell line. Cell. Physiol. Biochem., 2023, 57(2), 63-81. doi: 10.33594/000000616 PMID: 36945889
  24. Hong, J.; Hong, F.; Ze, Y.; Zhang, Y.Q. The nano-TiO2 exposure can induce hepatic inflammation involving in a JAK–STAT signalling pathway. J. Nanopart. Res., 2016, 18(6), 162. doi: 10.1007/s11051-016-3472-4
  25. Zhao, Y.; Tang, Y.; Liu, S.; Jia, T.; Zhou, D.; Xu, H. Foodborne TiO2 nanoparticles induced more severe hepatotoxicity in fructose-induced metabolic syndrome mice via exacerbating oxidative stress-mediated intestinal barrier damage. Foods, 2021, 10(5), 986. doi: 10.3390/foods10050986 PMID: 33946424
  26. Grissa, I.; ElGhoul, J.; Mrimi, R.; Mir, L.E.; Cheikh, H.B.; Horcajada, P. In deep evaluation of the neurotoxicity of orally administered TiO2 nanoparticles. Brain Res. Bull., 2020, 155, 119-128. doi: 10.1016/j.brainresbull.2019.10.005 PMID: 31715315
  27. Ze, Y.; Sheng, L.; Zhao, X.; Hong, J.; Ze, X.; Yu, X.; Pan, X.; Lin, A.; Zhao, Y.; Zhang, C.; Zhou, Q.; Wang, L.; Hong, F. TiO2 nanoparticles induced hippocampal neuroinflammation in mice. PLoS One, 2014, 9(3), e92230. doi: 10.1371/journal.pone.0092230 PMID: 24658543
  28. Krüger, K.; Schrader, K.; Klempt, M. Cellular response to titanium dioxide nanoparticles in intestinal epithelial caco-2 cells is dependent on endocytosis-associated structures and mediated by EGFR. Nanomaterials, 2017, 7(4), 79. doi: 10.3390/nano7040079 PMID: 28387727
  29. Hong, F.; Wang, L.; Yu, X.; Zhou, Y.; Hong, J.; Sheng, L. Toxicological effect of TiO2 nanoparticle-induced myocarditis in mice. Nanoscale Res. Lett., 2015, 10(1), 326. doi: 10.1186/s11671-015-1029-6 PMID: 26269254
  30. Ye, L.; Hong, F.; Ze, X.; Li, L.; Zhou, Y.; Ze, Y. Toxic effects of TiO 2 nanoparticles in primary cultured rat sertoli cells are mediated via a dysregulated Ca2+/PKC/p38 MAPK/NF-κB cascade. J. Biomed. Mater. Res. A, 2017, 105(5), 1374-1382. doi: 10.1002/jbm.a.36021 PMID: 28188686
  31. Bischoff, N.S.; de Kok, T.M.; Sijm, D.T.H.M.; van Breda, S.G.; Briedé, J.J.; Castenmiller, J.J.M.; Opperhuizen, A.; Chirino, Y.I.; Dirven, H.; Gott, D.; Houdeau, E.; Oomen, A.G.; Poulsen, M.; Rogler, G.; van Loveren, H. Possible adverse effects of food additive E171 (Titanium Dioxide) related to particle specific human toxicity, including the immune system. Int. J. Mol. Sci., 2020, 22(1), 207. doi: 10.3390/ijms22010207 PMID: 33379217
  32. Behnam, M.A.; Emami, F.; Sobhani, Z.; Dehghanian, A.R. The application of titanium dioxide (TiO2) nanoparticles in the photo-thermal therapy of melanoma cancer model. Iran. J. Basic Med. Sci., 2018, 21(11), 1133-1139. PMID: 30483386
  33. Zhang, D.Y.; Liu, H.; Younis, M.R.; Lei, S.; Chen, Y.; Huang, P.; Lin, J. In-situ TiO2-x decoration of titanium carbide MXene for photo/sono-responsive antitumor theranostics. J. Nanobiotechnology, 2022, 20(1), 53. doi: 10.1186/s12951-022-01253-8 PMID: 35090484
  34. Sargazi, S.; Er, S.; Sacide Gelen, S.; Rahdar, A.; Bilal, M.; Arshad, R.; Ajalli, N.; Farhan Ali Khan, M.; Pandey, S. Application of titanium dioxide nanoparticles in photothermal and photodynamic therapy of cancer: An updated and comprehensive review. J. Drug Deliv. Sci. Technol., 2022, 75, 103605. doi: 10.1016/j.jddst.2022.103605
  35. Liang, X.; Xie, Y.; Wu, J.; Wang, J. Petković M.; Stepić M.; Zhao, J.; Ma, J.; Mi, L. Functional titanium dioxide nanoparticle conjugated with phthalocyanine and folic acid as a promising photosensitizer for targeted photodynamic therapy in vitro and in vivo. J. Photochem. Photobiol. B, 2021, 215, 112122. doi: 10.1016/j.jphotobiol.2020.112122 PMID: 33433386
  36. Al-Nemrawi, N.; Hameedat, F.; Al-Husein, B.; Nimrawi, S. Photolytic controlled release formulation of methotrexate loaded in chitosan/TiO2 nanoparticles for breast cancer. Pharmaceuticals, 2022, 15(2), 149. doi: 10.3390/ph15020149 PMID: 35215259
  37. Garcia Diosa, J.A.; Gonzalez Orive, A.; Weinberger, C.; Schwiderek, S.; Knust, S.; Tiemann, M.; Grundmeier, G.; Keller, A.; Camargo Amado, R.J. TIO 2 nanoparticle coatings on glass surfaces for the selective trapping of leukemia cells from peripheral blood. J. Biomed. Mater. Res. B Appl. Biomater., 2021, 109(12), 2142-2153. doi: 10.1002/jbm.b.34862 PMID: 33982864
  38. Ma, M.; Cheng, L.; Wang, L.; Liang, X.; Yang, L.; Zhang, A. Enhanced photodynamic therapy of TiO2/N-succinyl-chitosan composite for killing cancer cells. Braz. J. Pharm. Sci., 2022, 58, e181116. doi: 10.1590/s2175-97902022e181116
  39. Wan, G.Y.; Wan, G-Y.; Liu, Y.; Chen, B-W.; Liu, Y-Y.; Wang, Y-S.; Zhang, N.; Liu, Y.; Chen, B-W.; Liu, Y-Y.; Wang, Y-S.; Zhang, N. Recent advances of sonodynamic therapy in cancer treatment. Cancer Biol. Med., 2016, 13(3), 325-338. doi: 10.20892/j.issn.2095-3941.2016.0068 PMID: 27807500
  40. Lin, X.; Huang, R.; Huang, Y.; Wang, K.; Li, H.; Bao, Y.; Wu, C.; Zhang, Y.; Tian, X.; Wang, X. Nanosonosensitizer-augmented sonodynamic therapy combined with checkpoint blockade for cancer immunotherapy. Int. J. Nanomedicine, 2021, 16, 1889-1899. doi: 10.2147/IJN.S290796 PMID: 33707944
  41. Lee, G.P.; Willis, A.; Pernal, S.; Phakatkar, A.; Shokuhfar, T.; Blot, V.; Engelhard, H.H. Targeted sonodynamic destruction of glioblastoma cells using antibody–titanium dioxide nanoparticle conjugates. Nanomedicine, 2021, 16(7), 523-534. doi: 10.2217/nnm-2020-0452 PMID: 33660528
  42. Kim, S.; Im, S.; Park, E.Y.; Lee, J.; Kim, C.; Kim, T.; Kim, W.J. Drug-loaded titanium dioxide nanoparticle coated with tumor targeting polymer as a sonodynamic chemotherapeutic agent for anti-cancer therapy. Nanomedicine, 2020, 24, 102110. doi: 10.1016/j.nano.2019.102110 PMID: 31666202
  43. Tan, X.; Huang, J.; Wang, Y.; He, S.; Jia, L.; Zhu, Y.; Pu, K.; Zhang, Y.; Yang, X. Transformable nanosensitizer with tumor microenvironment‐activated sonodynamic process and calcium release for enhanced cancer immunotherapy. Angew. Chem. Int. Ed., 2021, 60(25), 14051-14059. doi: 10.1002/anie.202102703 PMID: 33797161
  44. Aksel, M.; Kesmez, Ö. Yavaş A.; Bilgin, M.D. Titaniumdioxide mediated sonophotodynamic therapy against prostate cancer. J. Photochem. Photobiol. B, 2021, 225, 112333. doi: 10.1016/j.jphotobiol.2021.112333 PMID: 34688979
  45. Akram, M.W.; Raziq, F.; Fakhar-e-Alam, M.; Aziz, M.H.; Alimgeer, K.S.; Atif, M.; Amir, M.; Hanif, A.; Aslam Farooq, W. Tailoring of Au-TiO2 nanoparticles conjugated with doxorubicin for their synergistic response and photodynamic therapy applications. J. Photochem. Photobiol. Chem., 2019, 384, 112040. doi: 10.1016/j.jphotochem.2019.112040
  46. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod., 2020, 83(3), 770-803. doi: 10.1021/acs.jnatprod.9b01285 PMID: 32162523
  47. Huang, M.; Lu, J.J.; Ding, J. Natural products in cancer therapy: Past, present and future. Nat. Prod. Bioprospect., 2021, 11(1), 5-13. doi: 10.1007/s13659-020-00293-7 PMID: 33389713
  48. Varsha, K.; Sharma, A.; Kaur, A.; Madan, J.; Pandey, R.S.; Jain, U.K. Natural plant-derived anticancer drugs nanotherapeutics: A review on preclinical to clinical success. In: Nanostructures for Cancer Therapy Micro and Nano Technologies; 1st ed; Ficai, A.; Grumezescu, A.M., Eds.; Elsevier: New York, 2017; p. 775-809. doi: 10.1016/B978-0-323-46144-3.00028-3
  49. Oberlies, N.H.; Kroll, D.J. Camptothecin and taxol: Historic achievements in natural products research. J. Nat. Prod., 2004, 67(2), 129-135. doi: 10.1021/np030498t PMID: 14987046
  50. Leung, J.C.; Cassimeris, L. Reorganization of paclitaxel-stabilized microtubule arrays at mitotic entry: Roles of depolymerizing kinesins and severing proteins. Cancer Biol. Ther., 2019, 20(10), 1337-1347. doi: 10.1080/15384047.2019.1638678 PMID: 31345098
  51. Zhang, H.; Qiu, L. Bruton’s Tyrosine Kinase (BTK) inhibitors as sensitizing agents for cancer chemotherapy. In: Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy: Cancer Sensitizing Agents for Chemotherapy; 1st ed; Chen, Z.S.; Yang, D.H., Eds.; Academic Press: New York, 2019; p. 109-124. doi: 10.1016/B978-0-12-816435-8.00008-0
  52. Sideris, S.; Aoun, F.; Zanaty, M.; Martinez, N.C.; Latifyan, S.; Awada, A.; Gil, T. Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer. Mol. Clin. Oncol., 2016, 4(6), 1063-1067. doi: 10.3892/mco.2016.821 PMID: 27284445
  53. Zhang, Y.; Tang, Y.; Tang, X.; Wang, Y.; Zhang, Z.; Yang, H. Paclitaxel induces the apoptosis of prostate cancer cells via ros-mediated HIF-1α Expression. Molecules, 2022, 27(21), 7183. doi: 10.3390/molecules27217183 PMID: 36364008
  54. Gupta, A.; Gomes, F.; Lorigan, P. The role for chemotherapy in the modern management of melanoma. Melanoma Manag., 2017, 4(2), 125-136. doi: 10.2217/mmt-2017-0003 PMID: 30190915
  55. Khalifa, A.M.; Elsheikh, M.A.; Khalifa, A.M.; Elnaggar, Y.S.R. Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article. J. Control. Release, 2019, 311-312, 125-137. doi: 10.1016/j.jconrel.2019.08.034 PMID: 31476342
  56. Patel, V.K.; Sarim, K.M.; Patel, A.K.; Rout, P.K.; Kalra, A. Synthetic microbial ecology and nanotechnology for the production of Taxol and its precursors: A step towards sustainable production of cancer therapeutics. Design of Nanostructures for Theranostics Applications, 1st ed; Grumezescu, A.M., Ed.; William Andrew: New York, 2018, pp. 563-587.
  57. De Luca, R.; Profita, G.; Cicero, G. Nab-paclitaxel in pretreated metastatic breast cancer: Evaluation of activity, safety, and quality of life. OncoTargets Ther., 2019, 12, 1621-1627. doi: 10.2147/OTT.S191519 PMID: 30881017
  58. Raza, F.; Zafar, H.; Khan, M.W.; Ullah, A.; Khan, A.U.; Baseer, A.; Fareed, R.; Sohail, M. Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy. Materials Advances, 2022, 3(5), 2268-2290. doi: 10.1039/D1MA00961C
  59. Devanand Venkatasubbu, G.; Ramasamy, S.; Ramakrishnan, V.; Kumar, J. Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery. Adv. Powder Technol., 2013, 24(6), 947-954. doi: 10.1016/j.apt.2013.01.008
  60. Wang, T.; Jiang, H.; Wan, L.; Zhao, Q.; Jiang, T.; Wang, B.; Wang, S. Potential application of functional porous TiO2 nanoparticles in light-controlled drug release and targeted drug delivery. Acta Biomater., 2015, 13, 354-363. doi: 10.1016/j.actbio.2014.11.010 PMID: 25462846
  61. Wu, Z.; Setyawati, M.I.; Lim, H.K.; Ng, K.W.; Tay, C.Y. Nanoparticle-induced chemoresistance: The emerging modulatory effects of engineered nanomaterials on human intestinal cancer cell redox metabolic adaptation. Nanoscale, 2022, 14(39), 14491-14507. doi: 10.1039/D2NR03893E PMID: 36106385
  62. Li, Y.; Teng, X.; Wang, Y.; Yang, C.; Yan, X.; Li, J. Neutrophil delivered hollow titania covered persistent luminescent nanosensitizer for ultrosound augmented chemo/immuno glioblastoma therapy. Adv. Sci., 2021, 8(17), 2004381. doi: 10.1002/advs.202004381 PMID: 34196474
  63. Lee, S.; Kim, J.; Kim, J.; Hoshiar, A.K.; Park, J.; Lee, S.; Kim, J.; Pané, S.; Nelson, B.J.; Choi, H. A needle‐type microrobot for targeted drug delivery by affixing to a microtissue. Adv. Healthc. Mater., 2020, 9(7), 1901697. doi: 10.1002/adhm.201901697 PMID: 32129011
  64. Sun, D.; Gao, W.; Hu, H.; Zhou, S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm. Sin. B, 2022, 12(7), 3049-3062. doi: 10.1016/j.apsb.2022.02.002 PMID: 35865092
  65. Zhang, X.; Zhang, Y.; Ye, X.; Guo, X.; Zhang, T.; He, J. Overview of phase IV clinical trials for postmarket drug safety surveillance: A status report from the ClinicalTrials.gov registry. BMJ Open, 2016, 6(11), e010643. doi: 10.1136/bmjopen-2015-010643 PMID: 27881517
  66. Clinicaltrials.gov. 9 Studies found for: TiO2; U.S. National Library of Medicine: Bethesda (MD), 2023.
  67. Application of palliative treatment in children with brain stem glioma and recurrent high-grade tumors in the central nervous system with the nanomaterial NPt-Ca; U.S. National Library of Medicine: Bethesda, MD, 2022.
  68. Rodríguez, F.; Caruana, P.; De la Fuente, N.; Español, P.; Gámez, M.; Balart, J.; Llurba, E.; Rovira, R.; Ruiz, R.; Martín-Lorente, C.; Corchero, J.L.; Céspedes, M.V. Nano-based approved pharmaceuticals for cancer treatment: Present and future challenges. Biomolecules, 2022, 12(6), 784. doi: 10.3390/biom12060784 PMID: 35740909
  69. FDA. Nanotechnology Guidance Documents; U.S. Food and Drug Administration: Silver Spring (MD), 2018.
  70. Paradise, J. Regulating nanomedicine at the food and drug administration. AMA J. Ethics, 2019, 21(4), E347-E355. doi: 10.1001/amajethics.2019.347 PMID: 31012422

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers